![Leslie Aberman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leslie Aberman
Keine laufenden Positionen mehr
Profil
Leslie Aberman worked as Senior Director-Intellectual Property at Seagen Inc. from 2015 to 2015.
Prior to that, Aberman worked as Associate General Counsel at Infectious Disease Research Institute.
Currently, Aberman is Vice President-Legal Affairs at Neoleukin Therapeutics, Inc. from 2019 to 2023.
Aberman completed an undergraduate degree at Brown University and a graduate degree at Columbia Law School.
Ehemalige bekannte Positionen von Leslie Aberman
| Unternehmen | Position | Ende |
|---|---|---|
| NEUROGENE INC. | General Counsel | 01.03.2023 |
| SEAGEN INC. | Corporate Officer/Principal | 01.03.2015 |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology products to control infectious diseases | General Counsel | - |
Ausbildung von Leslie Aberman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology products to control infectious diseases | Commercial Services |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
